Great Point Partners’s Terns Pharmaceuticals TERN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,149,406	Closed	-$7.83M	–	37
2024 Q2	$7.83M	Sell	1,149,406 -160,569	-12%	-$1.09M	1.5%	24
2024 Q1	$8.59M	Hold	1,309,975	–	–	1.34%	27
2023 Q4	$8.5M	Buy	1,309,975 +664,076	+103%	+$4.31M	1.45%	24
2023 Q3	$3.25M	Buy	+645,899	New	+$3.25M	0.59%	36